News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
23hon MSN
Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
"Political directives should not prevent individuals from seeking safe and effective care that they desire and deserve," ...
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
A new COVID-19 variant is spreading across the U.S., including in New York, raising fresh concerns just as federal vaccine ...
In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...
6don MSN
Health and Human Services Secretary Robert F. Kennedy Jr. on Tuesday announced the removal of the COVID-19 vaccine from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback